Pregnancy SmartShop formulas

Is it safe? · Pregnancy Smart

What does factor V Leiden mean for pregnancy?

Assigned clinical reviewerMichael Yuzefovich· MD, FACOGDraft · pending clinical reviewUpdated

What does the evidence say about factor V Leiden during pregnancy?

  1. Factor V Leiden changes a protein involved in clotting. Some carriers never develop a clot. A result describes inherited susceptibility, not a current deep-vein clot or an inevitable pregnancy complication, and it needs to be interpreted alongside the personal history. 1
  2. One-copy and two-copy results have different implications. Decisions about anticoagulation also account for previous thrombosis, combined clotting variants and other clinical risks. A positive genetic report alone is not enough to copy another patient’s injection schedule. 2
  3. Pregnancy and the period after birth add clot risk through changes in clotting and blood flow. Discuss prolonged immobility, cesarean birth, family history and any previous clot with the maternity team. Ask what symptoms and delivery circumstances should trigger reassessment. 3
  4. ASRM’s recurrent-pregnancy-loss guidance does not recommend routine inherited-thrombophilia testing as a general explanation for repeated losses. Factor V Leiden is distinct from antiphospholipid syndrome. Testing and medicines should answer a defined clinical question rather than promise an improved outcome from a genetic result alone. 4
  5. If anticoagulation is indicated, the team selects an appropriate pregnancy regimen and plans around birth and postpartum care. Do not start, stop or replace a prescribed blood thinner independently. Reassess the plan when circumstances change, including after delivery. 2

Questions for your clot-risk consultation

  • First trimester. Bring your exact genetic result and details of any previous blood clot.
  • Second trimester. Ask how delivery, procedures or new immobility would change the plan.
  • Third trimester. Confirm postpartum follow-up and the symptoms that require emergency help.

Frequently asked questions

Does a positive result mean I currently have a blood clot?

No. It identifies an inherited clotting tendency. A suspected current clot requires clinical assessment and appropriate testing.

What do heterozygous and homozygous mean?

Heterozygous means one copy of the variant; homozygous means two. That distinction is relevant to risk assessment, along with the rest of your medical history.

Will every carrier need daily injections?

No. Guidance distinguishes different risk situations. Ask why medication is or is not recommended for your specific history and genotype.

Should everyone with recurrent miscarriage request this test?

No. Routine inherited-thrombophilia testing is not recommended as a general recurrent-loss assessment. The clinician may have a separate reason related to clot history or other findings.

Can I use another person’s blood-thinner schedule?

No. The indication, medicine and timing are individualized. A plan also needs instructions for labor, procedures and the period after birth.

Does clot risk disappear once the baby is born?

No. The postpartum period remains important. Before discharge, confirm your medicine plan if any, follow-up and warning signs.

What leg symptoms need prompt care?

New swelling, pain, warmth or discoloration, particularly in one limb, needs assessment. Tell the clinician about the pregnancy and clotting history.

When should I call emergency services?

Get emergency help for sudden breathing difficulty, chest pain, coughing blood or collapse. These can be signs of a pulmonary embolism and should not wait for a routine callback.

References

  1. Factor V Leiden thrombophilia

    MedlinePlus · https://medlineplus.gov/genetics/condition/factor-v-leiden-thrombophilia/

  2. Factor V Leiden Thrombophilia

    NCBI Bookshelf · https://www.ncbi.nlm.nih.gov/books/NBK1368/

  3. Understanding Your Risk for Blood Clots with Pregnancy

    CDC · https://www.cdc.gov/blood-clots/risk-factors/pregnancy.html

  4. Recurrent pregnancy loss: a committee opinion

    American Society for Reproductive Medicine · https://www.asrm.org/practice-guidance/practice-committee-documents/recurrent-pregnancy-loss-a-committee-opinion-2026/

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.